Synthesis and antimicrobial screening of 1,3,4-oxadiazole and clubbed thiophene derivatives

Journal of Saudi Chemical Society

Volumn 18, Issue 3, 2014, Pages 255-261

  Desai, N C ^a   Dodiya, Amit M ^a   Rajpara, Kiran M ^a   Rupala, Yogesh M ^a  

^a BHAVNAGAR UNIVERSITY   (India)

Author keywords

1,3,4 Oxdiazole; Antibacterial agents; Antifungal activity; MIC; Thiophene

Indexed keywords

EID: 84904095118     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2011.06.020     Document Type: Article

References (24)

1. Al-Bayati F.A., Al-Mola H.F. Antibacterial and antifungal activities of different parts of Tribulus terrestris L. growing in Iraq. Journal of Zhenjiang 2008, 9:154-159.
2. Almasirad A., Tabatabai S.A., Faizi M., Kebriaeezadeh A., Mehrabi N., Dalvandi A., Shafiee A. Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxdiazoles and 1,2,4-triazoles. Bioorg. Med. Chem. Lett. 2004, 14:6057-6059.
3. Bethge K., Pertz H.H., Rehse K. New oxadiazole derivatives showing partly antiplatelet, antithrombotic and serotonin antagonistic properties. Archiv. Pharm. 2005, 338:78-86.
4. + exchanger isoform-1 (NHE-1) inhibitors. Bioorg. Med. Chem. Lett. 2005, 15:2998-3001.
5. Desai N.C., Trivedi P.B. Synthesis and antimicrobial activity of some heterocyclic compounds. Indian J. Chem. 1993, 33B:497-500.
6. Desai, N.C., Dodiya, A., Kumar, M., 2010. Dimeric 2-(2-chlorophenyl)-quinazolin-4-ones as potential antimicrobial agents. Med. Chem. Res., (accepted for publication). doi:10.1007/s00044-011-9621-5.
7. Ghalem B.R., Mohamed B. Antimicrobial activity evaluation of the oleoresin oil of Pistacia vera L. African J. Pharm. Pharmacol. 2009, 3:92-96.
8. Kashaw S.K., Kashaw V., Mishra P., Jain N.K., Stables J.P. Synthesis and evaluation of anti-inflammatory and analgesic activity of 3-[(5-substituted-1,3,4-oxadiazol-2-yl-thio)acetyl]-2H-chromen-2-ones. Med. Chem. Res. 2010, DOI:10.1007/s00044-010-9494-z.
9. Ke S., Li Z., Qian X. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: Synthesis, evaluation, and role of urea moiety. Bioorg. Med. Chem. 2008, 16:7565-7572.
10. Khan M.T.H., Choudhary M.I., Khan K.M., Rani M., Rahman A.U. Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. Bioorg. Med. Chem. 2005, 13:3385-3395.
11. Kipnis F., Soloway H., Ornfelt J. 2-Acyloxyacetylthiophenes. J. Am. Chem. Soc. 1949, 71:10-11.
12. Kumar P.R., Raju S., Goud P.S., Sailaja M., Sarma M.R., Reddy G.O., Kumar M.P., Krishna Reddy V.V.R.M., Suresh T., Hedge P. Synthesis and biological evaluation of thiophene [3,2-b] pyrrole derivatives as potential anti-inflammatory agents. Bioorg. Med. Chem. 2004, 12:1221-1230.
13. Lee S.H., Seo H.J., Jung M.E., Park J., Lee S., Park H., Yoo J., Yun H., Na J., Kang S.Y., Song K., Kim M., Chang C., Kim J., Lee J. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity. J. Med. Chem. 2008, 51:7216-7233.
14. Macaey F., Rusu G., Pogrebnoi S., Gudima A., Stingaci E., Vlad L., Shvets N., Kandemirli F., Dimoglo A., Reynolds R. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacetrial activities. Bioorg. Med. Chem. 2005, 13:4842-4850.
15. Mathew V., Keshavayya J., Vaidya V.P. Heterocyclic system containing bridgehead nitrogen atom: synthesis and pharmacological activities of some substituted 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles. Eur. J. Med. Chem. 2006, 41:1048-1058.
16. Ogata M., Atobe H., Kushida H., Yamaoto K. In vitro sensitivity of mycoplasmas isolated from various animals and sewage to antibiotics and nitrofurans. J. Antibiot. 1971, 24:443-451.
17. Palmer J.T., Hirschbein B.L., Cheung H., McCarter J., Janc J.W., Yu Z.W., Wesolowski G. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors. Bioorg. Med. Chem. Lett. 2006, 16:2909-2914.
18. Prasad D.J., Mahalinga M., Holla B.S., Kumari N.S., Karthikeyan M.S. Antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing oxadiazoles. Euro J. Med. Chem. 2008, 43:25-31.
19. Queiroz M.R.P., Ferreira I.C.F.R., Gaetano Y.D., Kirsch G., Calhelha R.C., Estevinho L.M. Synthesis and antimicrobial activity studies of orthochlorodiarylamines and heteroaromatic tetracyclic systems in the benzo[b]thiophene series. Bioorg. Med. Chem. 2006, 14:6827-6831.
20. Schlecker R., Thieme P.C. The synthesis of antihypertensive 3-(1,3,4-oxadiazol-2-yl)phenoxypropanolahines. Tetrahedron 1988, 44:3289-3294.
21. Sriram D., Banerjee D., Yogeeswari P. Efavirenz mannich bases: synthesis, anti-HIV and antitubercular activities. J. Enzyme Inhib. Med. Chem. 2009, 24:1-5.
22. Thomson P., Naylor M.A., Everett S.A., Stratford M.R.L., Lewis G., Hill S., Patel K.B., Wardman P., Davis P.D. Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4. Mol. Cancer Therapeut. 2006, 5:2886-2894.
23. Vardan S.M.D., Smulyan H.M.D., Mookherjee S.M.D. Effects of tiodazosin, a new antihypertensive, hemodynamics and clinical variables. Clin. Pharm. Ther. 1983, 34:290-296.
24. 2 -1,3,4-oxadiazolines. A group of novel muscle relaxants. J. Med. Chem. 1966, 9:478-483.